Sodium‐glucose co‐transporter 2 inhibitor therapy: use in chronic kidney disease and adjunctive sodium restriction-Reference-Cited by-同舟云学术

Sodium‐glucose co‐transporter 2 inhibitor therapy: use in chronic kidney disease and adjunctive sodium restriction

Published:2022-05-27 Issue:10 Volume:52 Page:1666-1676
ISSN:1444-0903
Container-title:Internal Medicine Journal
language:en
Short-container-title:Internal Medicine Journal

Author:

Tiwary Mansi¹²³^ORCID,Milder Tamara Y.¹²⁴⁵,Stocker Sophie L.¹²³^ORCID,Day Richard O.¹²^ORCID,Greenfield Jerry R.¹⁴⁵^ORCID

Affiliation:

1. St Vincent's Clinical School University of New South Wales Sydney New South Wales Australia

2. Department of Clinical Pharmacology and Toxicology St Vincent's Hospital Sydney New South Wales Australia

3. School of Pharmacy University of Sydney Sydney New South Wales Australia

4. Department of Diabetes and Endocrinology St Vincent's Hospital Sydney New South Wales Australia

5. Healthy Ageing Garvan Institute of Medical Research Sydney New South Wales Australia

Publisher

Wiley

Subject

Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imj.15727

Reference45 articles.

1. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease;Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group;Kidney Int Suppl,2012

2. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

3. Australian Institute of Health and Welfare (AIHW). How many Australians have chronic kidney disease? Canberra: AIHW; 2020 [updated 2020 Jul 15; cited 2021 Oct 28]. Available from URL:https://www.aihw.gov.au/reports/chronic-kidney-disease/chronic-kidney-disease/contents/how-many-australians-have-chronic-kidney-disease

4. Effect of Sodium‐Glucose Cotransport‐2 Inhibitors on Blood Pressure in People With Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis of 43 Randomized Control Trials With 22 528 Patients

5. Effects of Sodium‐Glucose Cotransporter 2 Inhibitors on 24‐Hour Ambulatory Blood Pressure: A Systematic Review and Meta‐Analysis

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress on the role of extracellular vesicles in the pathogenesis of diabetic kidney disease;Renal Failure;2024-05-20

2. ‘We are somehow fixated on this being a diabetes drug’: a qualitative study exploring the views of cardiologists and nephrologists about sodium‐glucose cotransporter 2 inhibitor initiation;Internal Medicine Journal;2023-08-07